Zhengye Biotechnology Holding (ZYBT) Goodwill & Intangibles (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Goodwill & Intangibles of $14.5 million for Q4 2025, up 57.34% year-over-year from $9.2 million in Q4 2024, and up 582.33% quarter-over-quarter from $2.1 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Goodwill & Intangibles (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Goodwill & Intangibles for 3 consecutive years, with $14.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Goodwill & Intangibles rose 57.34% year-over-year to $14.5 million; the TTM figure through Dec 2025 stood at $14.5 million (up 57.34% YoY), while the FY2025 annual figure was $14.5 million, up 59.91% from the prior year.
- Goodwill & Intangibles improved to $14.5 million in Q4 2025 per ZYBT's latest filing, from $2.1 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $14.5 million in Q4 2025 and bottomed at $2.1 million in Q2 2025.
- Historically, Goodwill & Intangibles has averaged $8.7 million across 3 years, with a median of $9.1 million in 2023.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles gained 3.37% — and 2025, when it soared 57.34%.
- Zhengye Biotechnology Holding's Goodwill & Intangibles stood at $8.9 million in 2023, then increased by 3.37% to $9.2 million in 2024, then jumped by 57.34% to $14.5 million in 2025.
- Business Quant data shows ZYBT's Goodwill & Intangibles at $14.5 million in Q4 2025, $2.1 million in Q2 2025, and $9.2 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Zhengye Biotechnology Holding | 85.40 Mn | 78.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.50 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Dec 31, 2023 | 8.91 Mn |